Related Experiment Video
Updated: Jul 15, 2026
Lateral Molar Approach-Driven Transoral Endoscopic Procedure for Benign Infratemporal Fossa Tumor Resection
Published on: August 15, 2025
[Mitomycin C in head and neck surgical procedures]
M O Scheithauer1, H Riechelmann
1HNO-Universitätsklinik und Poliklinik Ulm. marc.scheithauer@uniklinikulm.de
Abstract:
Mitomycin C (MMC) is frequently used in combination chemotherapy. Its metabolites bind to DNA-molecules and causes DNA crosslinking, which interferes with the synthesis of DNA, RNA and proteins. MMC is thus able to reduce fibroblast proliferation. Moreover, MMC particularly inhibits the synthesis of extracellular matrix proteins including fibronectin and various collagens. These properties have been demonstrated in several experimental studies. Beside its merits in treatment of malignancies, MMC may thus be useful to prevent hypertrophic scars and keloids, adhesions and ostial restenosis following head and neck surgical procedures. Clinically, MMC has been applied to prevent scarring after ophthalmologic surgery. Recent experimental and clinical trials investigating the effects of MMC on wound healing following head and neck surgical procedures are reviewed.
Insights
Mitomycin C (MMC) effectively inhibits fibroblast proliferation and extracellular matrix synthesis, showing promise for preventing scarring and adhesions in head and neck surgeries.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Context:
- Mitomycin C (MMC) is a chemotherapy agent.
- Its DNA-crosslinking metabolites inhibit DNA, RNA, and protein synthesis.
- MMC reduces fibroblast proliferation and extracellular matrix protein synthesis.
Purpose:
- To review experimental and clinical trials on Mitomycin C's effects on wound healing.
- To explore MMC's potential in preventing scarring and adhesions in head and neck surgery.
Summary:
- Mitomycin C (MMC) metabolites bind to DNA, causing crosslinking and inhibiting synthesis of DNA, RNA, and proteins.
- This action reduces fibroblast proliferation and inhibits the synthesis of extracellular matrix proteins like fibronectin and collagens.
- Experimental studies support MMC's role in preventing hypertrophic scars, keloids, adhesions, and ostial restenosis.
Impact:
- Mitomycin C (MMC) demonstrates potential beyond chemotherapy, offering therapeutic benefits in preventing adverse tissue remodeling post-surgery.
- Clinical applications in ophthalmologic surgery for scar prevention highlight its efficacy.
- Further research in head and neck surgical procedures could establish MMC as a key agent in minimizing post-operative complications.
